Clinical Trial

Single Ascending Dose and Multiple Ascending Dose Evaluation of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MDI-2517 in Healthy Participants

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if drug MDI2517 is safe and to learn more about its drug effects in healthy participants. Healthy participants will take single or multiple doses of drug and the safety and drug levels will be measured.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-10-22.
Status change: Recruiting → Completed 2026-05-20
Trial Details
NCT Number NCT07220889
Lead Sponsor MDI Therapeutics, Inc.
Conditions Safety After Oral Intake
Enrollment 32 participants
Start Date 2025-11-04
Primary Completion 2025-12-16 (estimated)
Study Completion 2026-01-25 (estimated)
Updated on ClinicalTrials.gov 2026-05-22